0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Biologic Fate of Human Arterial Homografts

D. EMERICK SZILAGYI, M.D.; RICHARD T. McDONALD, M.D.; ROGER F. SMITH, M.D.; JOHN G. WHITCOMB, M.D.
AMA Arch Surg. 1957;75(4):506-529. doi:10.1001/archsurg.1957.01280160016003.
Text Size: A A A
Published online

In our experience—and insofar as the record shows, in the experience of others as well—the results of surgical procedures utilizing homologous arterial grafts in the surgical management of aneurysmal and occlusive arterial disease deteriorate as the postoperative follow-up period lengthens. The worsening of the results is not uniform in all anatomical areas and in all forms and degrees of disease. After four years' experience, from the point of view of technical excellence alone, the results of operations for aortic lesions appear best, although the long-term survival rate of patients with these lesions is unfavorably affected by the intercurrent manifestations of arteriosclerosis, mainly coronary thrombosis. Late deterioration of the results is commonest in patients with femoral and, especially, popliteal obliteration, a fact particularly disquieting, since this group of patients is the most numerous and generally has the best survival outlook. As a recent study1 shows, the commonest factor in the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();